同卵双生子间活体肾移植的诊治  

Diagnosis and treatment analysis of living kidney transplantation between identical twins

作　　者：周浩然 彭龙开[1] 张和栋 李腾芳 汤周琦 谢续标[1] 彭风华[1] 蓝恭斌[1] 王彧[1] 代贺龙 Zhou Haoran;Peng Longkai;Zhang Hedong;Li Tengfang;Tang Zhouqi;Xie Xubiao;Peng Fenghua;Lan Gongbin;Wang Yu;Dai Helong(Department of Kidney Transplantation,Organ Transplantation Center,The Second Xiangya Hospital of Central South University,Clinical Research Center for Organ Transplantation in Hunan Province,Changsha 410011,China)

机构地区：[1]中南大学湘雅二医院器官移植中心肾脏移植科,湖南省器官移植临床医学研究中心,长沙410011

出　　处：《中华泌尿外科杂志》2022年第12期936-937,共2页Chinese Journal of Urology

摘　　要：同卵双生子同胞间活体肾移植术后效果较好,但鲜有报道。2019年10月至2021年2月中南大学湘雅二医院收治2例受者,分别接受其孪生姐妹的肾脏行肾移植。2例受体的原发病分别为急进性肾小球肾炎1例,糖尿病肾病1例。2例术后均接受他克莫司/环孢素+吗替麦考酚酯+甲泼尼松龙三联抗排斥治疗。术后分别随访3.0年和1.5年,移植肾功能均良好。The effect of living kidney transplantation between identical twins is satisfied,but it is rarely reported.From October 2019 to February 2021,two recipients received kidney transplantation from their twin sisters in the Second Xiangya Hospital of Central South University.The primary disease of the two recipients was acute glomerulonephritis in 1 case and diabetic nephropathy in 1 case.Two recipients received tacrolimus/cyclosporine+mortemycophenol ester+methylprednisolone after surgery.The patients were followed up for 3.0 and 1.5 years,respectively,with renal function recovering well.

关 键 词：肾移植 同卵双生子 活体供肾 免疫抑制方案 

分 类 号：R699.2[医药卫生—泌尿科学]